SR9186 (ML368) is a potent CYP3A4 inhibitor used to inhibit the metabolism of midazolam to 1'-hydroxymidazolam, testosterone to 6β-hydroxytestosterone, and vinblastine to vinblastine M1; it also suppresses the hepatic-stage development of Plasmodium falciparum to block ivermectin metabolism.